IMAGENSYS, Surgery & Diagnostics Evolution Imagensys researches and develops devices for nuclear medicine and surgery that deliver technological innovation to diagnosis, follow-up and radio-guided surgery in cancer patients. It was founded in 2017 through an encounter between Dr. Alessandro Soluri’s team at CNR and Torrent Spa, a holding whose missions include the development and promotion of technology transfer and innovative start-ups. Imagensys saw an important opportunity for the prevention and treatment of cancers in the technologies developed by CNR, and hence a chance to establish itself in a continuous evolving market. To develop its technologies, Imagensys works with leading medical institutes such as the European Institute of Oncology, directed by Prof. Paolo Veronesi, and the SDN Foundation for Research and Higher Education in Naples, led by Prof. Marco Salvatore. The application of imaging technology to diagnostics and surgery is a major development which offers considerable opportunities for further growth. The instruments developed by Imagensys enable radio-guided surgery and diagnostic scintigraphy to take a step forward in terms of speed, accuracy and efficiency. In our opinion, this means supporting the difficult work of medical staff by simplifying and speeding up as much as possible the procedures related to the use of user-friendly instruments.